RTOG 0625: A phase II study of bevacizumab with irinotecan in recurrent glioblastoma (GBM)

keywords

  • Oncology
  • Science & Technology

Location

  • Orlando, FL

Conference

  • 45th Annual Meeting of the American-Society-of-Clinical-Oncology

issue

  • 15